Kursprognose für First Tracks Biotherapeutics Inc (TRAX)TRAXFirst Tracks Biotherapeutics Inc

Alphio's TRAX stock price prediction model matches the current First Tracks Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $44.47 (-1.36%). The 1-week path is $44.66 (-0.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

First Tracks Biotherapeutics (TRAX) is a good buy right now due to its current price of $44.05, which is significantly below the analyst price targets of $70 and $50, indicating substantial upside potential. The stock has shown strong momentum with a 5-day change of +27.83% and a year-to-date change of +95.69%. However, the main risk is its negative earnings per share (EPS) of -0.95 reported for the last quarter, which reflects ongoing financial challenges.

First Tracks Biotherapeutics Inc (TRAX) last closed at $45.0800018, losing -0.32%. These facts feed the 1-day and 1-week TRAX price prediction above.